The Journal of Thoracic and Cardiovascular Surgery, Vol 88, 654-658, Copyright © 1984 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
Thoracic manifestations of the acquired immune deficiency syndrome
HI Pass, DA Potter, AM Macher, C Reichert, JH Shelhammer, H Masur, F Ognibene, E Gelmann, HC Lane and A Fauci
The acquired immune deficiency syndrome is characterized by the development
of multiple recurrent opportunistic infections or unusual neoplasms in
individuals with no prior history of immune suppression. This report
summarizes the thoracic diseases encountered in such patients before after
death and the role of diagnostic techniques currently used in the
evaluation of thoracic disease in 15 patients with this syndrome. Efficacy
of treatment was determined by correlation with postmortem findings in all
patients. Pulmonary disease was present in all 15 patients and necessitated
23 transbronchial biopsies in 11 patients. Pneumocystis carinii pneumonia
and cytomegalovirus pneumonia were the most common findings. Nine open lung
biopsies in eight patients disclosed either Pneumocystis carinii pneumonia
or Kaposi's sarcoma. Esophageal disease was present in four patients, and
endoscopic evaluation demonstrated Candida esophagitis (two), esophageal
Kaposi's sarcoma (one), and cytomegalovirus esophagitis and Kaposi's
sarcoma (one). Mean time to death from diagnosis of acquired immune
deficiency syndrome was 7.7 months, with respiratory insufficiency being
the most common cause of death (9/15, 60%). Pneumocystis carinii pneumonia
was successfully eradicated in 70% of the patients. Candida esophagitis was
ameliorated in both patients with the disease. Unsuspected pulmonary
Kaposi's sarcoma, cytomegalovirus pneumonitis, and other infectious
pathogens were documented at autopsy. These data reveal that Pneumocystis
carinii pneumonia and Candida esophagitis can be managed successfully in
patients with acquired immune deficiency syndrome if appropriately
diagnosed. The major cause of death in this series was pulmonary
insufficiency, often the result of severe cytomegalovirus infection.
Thoracic surgeons must continue to play an aggressive and important role in
the early diagnosis and management of potentially treatable pulmonary and
esophageal disease in these patients.